QUOTED. March 15, 2019. John Russell.
Cardiva Medical believes it's in a unique position to help the growing number of patients who undergo catheter-based cardiovascular procedures requiring relatively large catheters, especially electrophysiology procedures like cardiac ablation. See what Cardiva CEO John Russell said about EP procedures here.
"We're at the dawn of a new era for closure in EP procedures. We think this is where the standard arterial closure market was 20 years ago when closure devices were first introduced and for many of the same reasons." –John Russell, CEO, Cardiva Medical Inc.
Click here for a free trial of Medtech Insight